Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025
About 30 minutes before the market closed Monday, the broader market index was up 0.3%, while the blue-chip companies gained 0.9%. Meanwhile, the Nasdaq Composite dropped 0.5%. Some stocks were recovering from Friday losses after inflation data came in higher than expected, coupled with weak consumer sentiment, which heightened concerns about the U.S. economy's stability, according to Investopedia.
As investors react to daily market changes, ongoing uncertainty continues to affect the market. During such times, insider trading often garners attention, as executive purchases of company stock can signal optimism about the company's prospects. However, insider sales do not always indicate a lack of confidence—they may be influenced by personal financial reasons or a need for diversification. Executives often follow pre-arranged plans, like 10b5-1, to ensure transparency. While insider trading can offer valuable insights, it should be considered alongside a company's financial health, market conditions, and industry shifts.
What are some of the stocks insiders have been buying the most in the first quarter of the year? To find out, we used Insider Monkey's insider trading stock screener, focusing only on stocks where at least five insiders had purchased shares in January, February, and March. From there, we ranked the 20 stocks with the highest number of insiders purchasing shares.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
With each stock, we note the average price per share of these purchases and the stock's market capitalization.
A doctor looking at their computer, discussing their patient's care options with a group of experts.
Market Cap: $1.12 billion
Number of insiders buying: 9
The eighth stock among the 20 that insiders were buying the most in the first quarter of the year is Evolent Health, a provider of healthcare plans and benefits management services. Through its subsidiary Evolent Health LLC, it offers specialty care management services in oncology, cardiology, and musculoskeletal markets, focusing on improving patient outcomes and reducing costs. Its integrated platform supports health plan administration and value-based business infrastructure, offering services such as pharmacy benefits management, risk management, analytics, and leadership support. Additionally, Evolent provides Identifi, a proprietary technology system that aggregates data, manages care workflows, and engages patients, as well as Machinify Auth, a software platform utilizing artificial intelligence to optimize care processes. The company is based in Arlington, Virginia,
For the full year 2024, the company reported revenue of $2.55 billion, 30.1% up from $1.96 billion in 2023. The net loss for the year was $93.45 million, an improvement from the $142.26 million loss in 2023. Looking ahead to 2025, Evolent expects revenue between $2.06 billion and $2.11 billion, reflecting an annual growth rate of 15%-18%, excluding the impact of one-time contract changes in three Performance Suite contracts. The company also anticipates adjusted EBITDA in the range of $135 million to $165 million.
In March, nine insiders, including the company's CEO, purchased a total of around $1.35 million worth of Evolent Health shares at an average price of $9.10 per share. Currently, the stock trades at $9.53 per share, having declined 15.29% year-to-date and 70.15% over the past 12 months.
Fourteen analysts rate Evolent Health stock as 'Buy,' according to MarketBeat. The average price target of $17.71 suggests an upside of 85.88% from the latest price.
Evolent Health is also one of the 12 stocks that are about to explode.
Overall, EVH ranks 8th on our list of stocks insiders were buying in Q1 2025. While we acknowledge the potential of EVH our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than EVH but that trades at less than 5 times its earnings, check out our report about the .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
27 minutes ago
- Business Insider
‘This Is a No-Go Zone,' Says Top Investor About Figma Stock
Figma (NYSE:FIG) stock made a splash when it went public late last month, with shares tripling on their first day of trading. But the early euphoria has faded – the stock now trades about 31% below its day-one close. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Even so, the IPO was a significant milestone for the design platform, which counts roughly 13 million active users and has delivered steady revenue growth over the past two years, including a 41% jump in Q2 2025. Yet, impressive growth alone isn't enough to sway everyone. Top investor Michael Wiggins De Oliveira, who is among the top 3% of TipRanks' stock pros, warns that jumping on the bandwagon now could be a costly mistake. 'I don't see a clear enough inflection for Figma to maintain its pricing power or growth profile over the next few quarters to justify its current multiple,' Wiggins De Oliveira explains. While the investor acknowledges the 'impressive userbase' and rapid revenue growth, he points to concerns that weaken the risk-reward profile. Chief among them is the growing narrative that AI could erode Figma's competitive moat. With technological disruption moving at breakneck speed, Wiggins De Oliveira questions whether the company can sustain its pace of year-over-year growth. Competitors could introduce advances that replicate core features of Figma's platform, undermining its uniqueness. 'The company is up against a challenging narrative that AI could disrupt much of its underlying offering,' the investor adds, projecting that revenue growth could slow to 30%–35% annually. Beyond growth concerns, Wiggins De Oliveira also casts doubt on the quality of Figma's cash flow profile. While the company posted a notable swing to nearly $100 million in free cash flow in Q1 2025, the investor cautions that the figure may have been flattered by one-off factors tied to its IPO filing. Stripping those out, he estimates sustainable annual free cash flow closer to $250 million at best – a figure that, when set against its market cap, leaves FIG trading at an expensive ~160x forward free cash flow. 'Outperformance comes from patience and picking your spots – and for me, FIG just doesn't make the cut,' concludes Wiggins De Oliveira, who rates FIG a Sell. (To watch Michael Wiggins De Oliveira's track record, click here) For now, FIG is too new to have analyst ratings, but with its IPO, early volatility, and high-profile debate, Wall Street attention is likely to grow in the months ahead. (See FIG stock analysis) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
an hour ago
- Yahoo
Retail trading trends: Top names investors are buying
Retail traders, like their institutional counterparts, are feeling bullish as the market trades near record highs. Investopedia editor in chief Caleb Silver shares the findings of Investopedia's recent investor survey, including some of the top names retail investors are trading and where they should invest extra cash. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend. Well, American workers are increasingly investing stocks. We know that in their retirement funds. Vanguard Group found workers in their late 30s at 88% of their 401Ks in stocks last year. That's versus 82% a decade earlier. And a new sentiment survey from Investopedia shows retail traders, they're more interested in individual names than ETFs with the data showing, if folks had 10,000, 22% of respondents would put that money into individual names. Caleb Silver, Investopedia editor-in-chief, he's with me now. Caleb, let's start. I wanna know how Investopedia fans, how are they feeling? What's the vibe there? The vibes are strong. The vibes are immaculate. Record highs will do that to you, right? And we've had a lot of them lately, and they see this deregulatory environment. They see the fact that rates are coming down, and they've seen some outperformance not just in their favorite stocks, which look a lot like the top of the S&P 500, but in a lot of smaller stocks as well. So, they've been paid for their patience. They've been paid for hanging in there, and they've been more aggressive, by and large, than a lot of institutional investors. PS, institutional investors, according to Bank of America's most recent fund manager survey, also as optimistic as they've been in six months, but again, higher highs will make you feel pretty good. So good vibes. What do they do with those vibes? What are the names they wanna own? Yeah, they own their home cooking. They own the stocks that they've owned ever since they probably got in this game, and that is the top of the S&P 500. Nvidia tops that list. Palantir new, but rising onto that list. Microsoft, Apple, Amazon, of course. You see some Berkshire Hathaway in there. You see a little Costco sprinkled in there and some banks like JP Morgan, but by and large, mega cap tech, anything AI related of size, they stick with them. They've been paid well and handsomely for sticking with their bets. Now another question you ask, which I always think is interesting. You also ask, "Hey, what do you wanna own 10 years from now?" What was their answer? Yeah. Well, a lot of the same stocks. Nvidia's on the top of that list as well. Palantir, one of the top stocks on that list as well. Microsoft, I see there as well. Even Alphabet. So, not a lot of change, because why change when we are really in the land of the giants. The big stocks move the market. We were talking with a guest earlier that says, "They are the market." If you're not in these big stocks, you're not just moving, you're not having that outperformance. So, they have to be in them. And they've been rewarded, again, for holding these stocks. You don't see a lot of them exploring a lot into other sectors beyond big tech right now, and uh beyond in smaller stocks. But you do see them globbing onto the same things that have delivered the performance that look like the QQQs, that look like the SPY's. That's where they stuck their money. That's where they intend to stick their money, and as the market has been rising for the past couple months, that's where they put even more of their money. And you also ask them, I like this part of the survey. You ask them, "Listen, if you had an extra 10 large, an extra $10,000, where would you put it to work? Where would you commit capital?" What was their answer? Yeah. This is the ultimate discretionary question. What would you do with an extra 10,000 assuming you could invest it? And individual stocks top that list. And when you have this rising bull market and records after records coming in day after day, that's what you get. They want to own the individual names because that's where the performance has been. Second on that list is ETF. They want some diversification there. That makes a lot of sense as well. But basically, keep buying the same stocks that have delivered the returns, and that have made them 401K millionaires. And when you look at survey after survey, we have more than ever right now, as you mentioned Vanguard saying more and more people contributing stocks to their 401K plans. We are a stock heavy nation. If you ask them some of these questions, you know, let's say six months ago or 12 months ago, has there been a big difference? I mean, has it evolved a lot? Absolutely. And they went from trying to be safe with CDs and high-yield savings to back to stocks, back to ETFs. So, you see that seesaw depending on behavior and depending on how the market's doing right now. When we had the big sell-off, everyone was running for cover. There was gold was topping that list as well. But they were looking for places to be safe. ETFs were a little bit stronger than individual stocks because of the diversification. They'd seen some big tumbles in some of their favorite stocks. But when you get a bull market like this, when you get records after records, people want to own individual stocks. Again, biggest stocks in the market just keep getting bigger. And when we talk about the folks you're surveying here, remind me, Caleb, the Investopedia fan, who is that fan? What's the demo? Yeah, the Investopedia reader is right here. You and me, right? 18 to 80, self-directed, educated investors who like to invest their own money. Maybe they also get professional advice to do it as well, but they're interested in learning how this works, and they come to us to get smarter about it. But we're talking about, you know, adults, average age in their 40s or so, but we do have this big range of people who are just starting to learn to people who are kind of nearing the end of their investing journey, but still want to stay smart. So, this is kind of everybody, and it's a pretty good representation when you think about the size of our reader base. Related Videos 3 reasons the Fed hasn't cut rates yet this year How Trump's pressure on Fed Chair Powell could backfire Stocks close mixed, the Dow ends the week higher Applied Materials' Forecast Rattles Investors Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
an hour ago
- Business Insider
J.P. Morgan Sticks to Its Buy Rating for Nisource (NI)
In a report released on August 13, Richard Sunderland from J.P. Morgan maintained a Buy rating on Nisource, with a price target of $46.00. The company's shares closed yesterday at $41.95. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Sunderland is a 3-star analyst with an average return of 2.7% and a 54.97% success rate. Sunderland covers the Utilities sector, focusing on stocks such as Atmos Energy, Spire, and Edison International. In addition to J.P. Morgan, Nisource also received a Buy from BMO Capital's James Thalacker in a report issued on August 6. However, on August 14, TR | OpenAI – 4o downgraded Nisource (NYSE: NI) to a Hold. The company has a one-year high of $43.51 and a one-year low of $31.90. Currently, Nisource has an average volume of 4.23M. Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of NI in relation to earlier this year. Most recently, in June 2025, Melanie B. Berman, the EVP Administration & CHRO of NI sold 6,227.00 shares for a total of $245,468.34.
